Visceral fat (VF) excess has been associated with decreased peripheral insulin sensitivity and has been suggested to contribute to hepatic insulin resistance. However, the mechanisms by which VF impacts on hepatic glucose metabolism and the quantitative role of VF in glycemic control have not been investigated. In the present study 63 type 2 diabetic subjects (age, 55 +/- 1 yr; fasting plasma glucose, 5.5-14.4 mmol/liter; hemoglobin A(1c), 6.1-11.7%) underwent measurement of 1) fat-free mass ((3)H(2)O technique), 2) sc and visceral abdominal fat area (magnetic resonance imaging), 3) insulin sensitivity (euglycemic insulin clamp), 4) endogenous glucose output ([(3)H]glucose infusion technique), and 5) gluconeogenesis ((2)H(2)O method). After adjustment for sex, age, body mass index, diabetes duration, ethnicity, and sc fat area, VF area was positively related to fasting hyperglycemia (partial r = 0.46; P = 0.001) as well as to hemoglobin A(1c) (partial r = 0.50; P = 0.0003). Insulin sensitivity was reciprocally related to VF independently of body mass index (partial r = 0.33; P = 0.01). In contrast, the relation of basal endogenous glucose output to VF was not statistically significant. This lack of association was explained by the fact that VF was positively associated with gluconeogenesis flux (confounder-adjusted, partial r = 0.45; P = 0.003), but was reciprocally associated with glycogenolysis (partial r = 0.31; P < 0.05). We conclude that in patients with established type 2 diabetes, VF accumulation has a significant negative impact on glycemic control through a decrease in peripheral insulin sensitivity and an enhancement of gluconeogenesis.

Metabolic effects of visceral fat accumulation in Type 2 diabetes

Gastaldelli A;
2002

Abstract

Visceral fat (VF) excess has been associated with decreased peripheral insulin sensitivity and has been suggested to contribute to hepatic insulin resistance. However, the mechanisms by which VF impacts on hepatic glucose metabolism and the quantitative role of VF in glycemic control have not been investigated. In the present study 63 type 2 diabetic subjects (age, 55 +/- 1 yr; fasting plasma glucose, 5.5-14.4 mmol/liter; hemoglobin A(1c), 6.1-11.7%) underwent measurement of 1) fat-free mass ((3)H(2)O technique), 2) sc and visceral abdominal fat area (magnetic resonance imaging), 3) insulin sensitivity (euglycemic insulin clamp), 4) endogenous glucose output ([(3)H]glucose infusion technique), and 5) gluconeogenesis ((2)H(2)O method). After adjustment for sex, age, body mass index, diabetes duration, ethnicity, and sc fat area, VF area was positively related to fasting hyperglycemia (partial r = 0.46; P = 0.001) as well as to hemoglobin A(1c) (partial r = 0.50; P = 0.0003). Insulin sensitivity was reciprocally related to VF independently of body mass index (partial r = 0.33; P = 0.01). In contrast, the relation of basal endogenous glucose output to VF was not statistically significant. This lack of association was explained by the fact that VF was positively associated with gluconeogenesis flux (confounder-adjusted, partial r = 0.45; P = 0.003), but was reciprocally associated with glycogenolysis (partial r = 0.31; P < 0.05). We conclude that in patients with established type 2 diabetes, VF accumulation has a significant negative impact on glycemic control through a decrease in peripheral insulin sensitivity and an enhancement of gluconeogenesis.
2002
Istituto di Fisiologia Clinica - IFC
Inglese
87
11
5098
5103
7
http://www.ncbi.nlm.nih.gov/pubmed/12414878?dopt=Citation
HEPATIC GLUCOSE-PRODUCTION
ADIPOSE-TISSUE
FASTING HYPERGLYCEMIA
INSULIN-SECRETION
GLYCEMIC CONTROL
Il nostro laboratorio ha implementato assieme al gruppo del dr. Landau della CWRU di Cleveland, USA, la tecnica dell’ acqua deuterata (D2O) che è generalmente ritenuta il gold standard per la misura della GNG totale in vivo. Questo articolo è stato pubblicato su una rivista di visibilità internazionale con impact factor 5199 ed è stato citato dai seguenti articoli 1. Epidemiology of Diabetes J. Clin. Pharmacol., 2004; 44(4): 397 – 405 2. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration Am. J. Clinical Nutrition, 2003; 78(5): 928 – 934 3. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E906 - 916. 4. Diabetes Mellitus in the Era of Proteomics Mol. Cell. Proteomics, 2003; 2(6): 399 - 404.
8
info:eu-repo/semantics/article
262
Gastaldelli, A; Miyazaki, Y; Pettiti, M; Matsuda, M; Mahankali, S; Santini, E; Defronzo, R A; Ferrannini, E
01 Contributo su Rivista::01.01 Articolo in rivista
reserved
File in questo prodotto:
File Dimensione Formato  
prod_169380-doc_56664.pdf

non disponibili

Descrizione: Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
Dimensione 152.29 kB
Formato Adobe PDF
152.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/144539
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 223
social impact